Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Paolo Pronzato
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Concepts & Ideas
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
35
Bertelli, Gianfilippo
24
Vigani, A
23
Amoroso, Domenico
21
Gardin, Giovanni
21
Vaira, F
19
Lionetto, Rita
18
Ardizzoni, Andrea
16
Conte, Pier Franco
16
Repetto, Lazzaro
13
Pensa, F
13
Sertoli, Mario Roberto
12
Tognoni, Alessandra
10
Venturini, Marco
10
Queirolo, Paola
8
Rubagotti, Alessandra
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Paolo Pronzato (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Aita Marianna; Fasola Gianpiero; Defferrari Carlotta; Brianti Annalisa; Bello Maria Giovanna Dal; Follador Alessandro; Sinaccio Graziella; Pronzato Paolo; Grossi Francesco
Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer.
Critical reviews in oncology/hematology 2008;68(3):183-96.
-
2008: Guarneri Valentina; Frassoldati Antonio; Bruzzi Paolo; D'Amico Roberto; Belfiglio Maurizio; Molino Annamaria; Bertetto Oscar; Cascinu Stefano; Cognetti Francesco; Di Leo Angelo; Pronzato Paolo; Crinó Lucio; Agostara Biagio; Conte PierFranco
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Clinical breast cancer 2008;8(5):453-6.
-
2008: Roncella Silvio; Ferro Paola; Bacigalupo Bartolomeo; Dessanti Paolo; Pronzato Paolo; Franceschini Maria Cristiana; Pratticò Luca; Carletti Anna Maria; Canessa Pier Aldo; Fontana Vincenzo; Fais Franco; Pistillo Maria Pia; Fedeli Franco
Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2008;17(1):28-33.
-
2008: Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):299-307.
-
2007: Clavarezza Matteo; Del Mastro Lucia; Pronzato Paolo; Bruzzi Paolo; Venturini Marco
Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Journal of the National Cancer Institute 2007;99(13):1050-1; author reply 1051-2.
-
2006: Roncella S; Ferro P; Bacigalupo B; Dessanti P; Giannico A; Gorji N; Moroni M; Tozzini S; Pensa F; Gianquinto D; Fais F; Pronzato P; Fedeli F
Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.
Journal of experimental & clinical cancer research : CR 2006;25(1):65-72.
-
2005: Venturini Marco; Del Mastro Lucia; Aitini Enrico; Baldini Editta; Caroti Cinzia; Contu Antonio; Testore Franco; Brema Fulvio; Pronzato Paolo; Cavazzini Giovanna; Sertoli Mario Roberto; Canavese Giuseppe; Rosso Riccardo; Bruzzi Paolo
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
Journal of the National Cancer Institute 2005;97(23):1724-33.
-
2005: Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Journal of experimental & clinical cancer research : CR 2005;24(2):265-71.
-
2004: Chiara Silvana; Tognoni Alessandra; Pastrone Ilaria; Tomasello Laura; Brema Fulvio; Di Costanzo Gianna; Folco Ugo; Pronzato Paolo;
Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
Gynecologic oncology 2004;93(2):474-8.
-
2003: Manna Annunziata; Cordani Stefano; Canessa Pieraldo; Pronzato Paolo
CMV infection and pneumonia in hematological malignancies.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2003;9(3):265-7.
-
2002: Bertelli G; Venturini M; Del Mastro L; Bergaglio M; Sismondi P; Biglia N; Venturini S; Porcile G; Pronzato P; Costantini M; Rosso R
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):883-8.
-
2002: Tognoni A; Pensa F; Vaira F; Vigani A; Caness P; Sinaccio G; Pronzato P
A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer.
Journal of chemotherapy (Florence, Italy) 2002;14(3):296-300.
-
2001: Pronzato P; Vigani A; Tognoni A; Vaira F; Canessa P
Anthracyclines in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S57-9.
-
2001: Tognoni A; Pensa F; Vaira F; Vigani A; Bancalari L; Fiasella L; Maggiani R; Canessa P; Pronzato P
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer.
Journal of chemotherapy (Florence, Italy) 2001;13(2):202-5.
-
2001: Del Mastro L; Venturini M; Lionetto R; Carnino F; Guarneri D; Gallo L; Contu A; Pronzato P; Vesentini L; Bergaglio M; Comis S; Rosso R
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2213-21.
-
2001: Pronzato P; Queirolo P; Vecchio S; Lionetto R; Del Mastro L; Venturini M; Gardin G; Alama A; Sertoli M R
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy.
Oncology 2001;60(1):88-93.
-
2000: Vigani A; Pensa F; Vaira F; Bancalari L; Cordani S; Maggiani R; Canessa P; Pronzato P
Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer.
Anticancer research 2000;20(5C):4015-8.
-
2000: Tognoni A; Pronzato P; Cadenotti L; Ghio E; Manna N; Pensa F; Marino L
Sequential high dose-density chemotherapy in advanced ovarian cancer.
Anticancer research 2000;20(5C):3957-61.
-
2000: Venturino A; Comandini D; Simoni C; Merlini L; Naso C; Palumbo R; Fusco V; Porcile G; Pronzato P; Rosso R; Repetto L
Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin.
Breast cancer research and treatment 2000;60(3):195-200.
-
1999: Tognoni A; Cadenotti L; Pensa F; Vaira F; Vigani A; Bancalari L; Cordani S; Maggiani R; Canessa P A; Pronzato P
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.
Journal of chemotherapy (Florence, Italy) 1999;11(4):306-9.
-
1998: Pronzato P; Lionetto R; Botto F; Pensa F; Tognoni A
High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.
British journal of cancer 1998;78(6):777-80.
-
1998: Pronzato P; Tognoni A; Pensa F; Vaira F; Vigani A
A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer.
Journal of chemotherapy (Florence, Italy) 1998;10(4):326-30.
-
1998: Pronzato P; Botto F; Ghio E; Pensa F; Tognoni A; Vaira F; Vigani A; Neri E
A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer.
Journal of chemotherapy (Florence, Italy) 1998;10(3):254-7.
-
1998: Pronzato P; Losardo P; Pensa F; Tognoni A
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study.
Cancer chemotherapy and pharmacology 1998;41(6):513-6.
-
1997: Pronzato P; Vigani A; Pensa F; Vanoli M; Tani F; Vaira F
Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.
American journal of clinical oncology 1997;20(5):519-21.
-
1997: Pronzato P; Pensa F; Vaira F; Vigani A
[Low-dose GM-CSF and dose intensity of antineoplastic agents]
Tumori 1997;83(5 Suppl):S8-12.
-
1997: Baldini E; Gardin G; Giannessi P; Brema F; Camorriano A; Carnino F; Naso C; Pastorino G; Pronzato P; Rosso R; Rubagotti A; Torretta G; Conte P F
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy.
Tumori 1997;83(5):829-33.
-
1997: Pronzato P; Vigani A; Pensa F; Botto F; Ghio E; Neri E; Tognoni A; Vaira F
A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility study.
Anticancer research 1997;17(5B):3873-6.
-
1997: Pronzato P; Bertelli G; Bruna F; Tani F; Vaira F; Vanoli M; Vigani A
Intensified M-VEC chemotherapy with G-CSF support as outpatient treatment for advanced bladder cancer.
Anticancer research 1997;17(3C):2325-7.
-
1997: Pennucci M C; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
Cancer 1997;79(10):1897-902.
-
1997: Pronzato P; Queirolo P; Landucci M; Vaira F; Vigani A; Gipponi M; Cafiero F
Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancer.
Breast cancer research and treatment 1997;42(2):183-6.
-
1996: Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina R C; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte P F; Rosso R
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3112-20.
-
1996: Conte P F; Baldini E; Gardin G; Pronzato P; Amadori D; Carnino F; Monzeglio C; Gentilini P; Gallotti P; DeMicheli R; Venturini M; Rubagotti A; Rosso R
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):487-90.
-
1996: Pronzato P; Bertelli G; Vigani A; Vaira F
A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.
British journal of cancer 1996;73(11):1425-7.
-
1996: Gardin G; Barone C; Nascimben O; Ianniello G; Sturba F; Contu A; Pronzato P; Rosso R
Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study.
European journal of cancer (Oxford, England : 1990) 1996;32A(1):176-7.
-
1996: Repetto L; Giannessi P G; Campora E; Pronzato P; Vigani A; Naso C; Spinelli I; Conte P F; Rosso R
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.
Breast cancer research and treatment 1996;39(2):235-8.
-
1996: Pronzato P; Ghio E; Losardo P L; Landucci M; Vaira F; Vigani A
Carboplatin and vinorelbine in advanced non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1996;37(6):610-2.
-
1995: Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G
Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
Anticancer research 1995;15(6B):2679-82.
-
1995: Sertoli M R; Bruzzi P; Pronzato P; Queirolo P; Amoroso D; Del Mastro L; Venturini M; Vigani A; Bertelli G; Campora E
Randomized cooperative study of perioperative chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2712-21.
-
1995: Pronzato P; Losardo P L; Vaira F; Vigani A; Landucci M; Ghio E
Granisetron-dexamethasone combination for multiple day cisplatin.
Anticancer research 1995;15(5B):2261-3.
-
1995: Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
Carboplatin, methotrexate, and vinblastine in outpatients with advanced transitional cell carcinoma of the bladder.
American journal of clinical oncology 1995;18(3):223-5.
-
1995: Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
Anticancer research 1995;15(2):517-9.
-
1995: Gardin G; Rosso R; Campora E; Repetto L; Naso C; Canavese G; Catturich A; Corvò R; Guenzi M; Pronzato P
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1428-33.
-
1994: Pronzato P; Bertelli G; Losardo P; Landucci M
What do advanced cancer patients know of their disease? A report from Italy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(4):242-4.
-
1994: Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
Anticancer research 1994;14(3B):1413-5.
-
1994: Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
Carboplatin and etoposide as outpatient treatment of advanced non-small-cell lung cancer.
Chemotherapy 1994;40(2):144-8.
-
1994: Bertelli G; Dini D; Forno G B; Gozza A; Silvestro S; Venturini M; Rosso R; Pronzato P
Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results.
Journal of cancer research and clinical oncology 1994;120(8):505-6.
-
1994: Gardin G; Alama A; Rosso R; Campora E; Repetto L; Pronzato P; Merlini L; Naso C; Camoriano A; Meazza R
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.
Breast cancer research and treatment 1994;32(3):311-8.
-
1994: Pronzato P; Bertelli G; Vaira F; Vigani A; Losardo P
Mitoxantrone and 5-fluorouracil modulated by the pure (6S) stereoisomer of leucovorin as second-line chemotherapy for advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1593-4.
-
1993: Pronzato P; Rubagotti A; Amoroso D; Bertelli G; Queirolo P; Sertoli M R; Rosso M; Gallotti P; Monzeglio C; Rosso R
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.
American journal of clinical oncology 1993;16(6):522-5.
-
1993: Baldini E; Gardin G; Naso C; Pronzato P; Rosso R; Rubagotti A; Monzeglio C; Brema F; Pastorino G; Amadori D
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
Annals of the New York Academy of Sciences 1993;698():418-22.
-
1993: Pronzato P; Bertelli G; Rosso M
A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancer.
Annals of the New York Academy of Sciences 1993;698():357-61.
-
1993: Rosso R; Gardin G; Pronzato P; Camoriano A; Merlini L; Naso C; Rosso M; Barone C; Nascimben O; Ianniello G
The role of lonidamine in the treatment of breast cancer patients.
Annals of the New York Academy of Sciences 1993;698():349-56.
-
1993: Pronzato P; Bertelli G; Gardin G; Rubagotti A; Conte P F; Rosso R
Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients.
Oncology 1993;50(6):460-5.
-
1993: Naso C; Simoni C; Merlini L; Rosso M; Pronzato P; Repetto L; Gardin G; Rosso R
Lymphoblastoid interferon in advanced breast cancer: a phase II study.
Journal of chemotherapy (Florence, Italy) 1993;5(4):258-61.
-
1993: Pronzato P; Miglietta L; Rubagotti A; Bertelli G; Queirolo P; Guenzi M; Sertoli M R; Vitale V; Rosso R
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity.
American journal of clinical oncology 1993;16(1):58-60.
-
1992: Campora E; Pronzato P; Amoroso D; Bertelli G F; Venturini M; Baldini E; Brunetti I; Sertoli M R; Conte P; Rosso R
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.
Anticancer research 1992;12(5):1555-8.
-
1992: Repetto L; Miglietta L; Gardin G; Naso C; Giudici S; Merlini L; Queirolo P; Campora E; Pronzato P; Rosso R
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(2):165-6.
-
1991: Miglietta L; Repetto L; Gardin G; Amoroso D; Giudici S; Naso C; Merlini L; Queirolo P; Campora E; Pronzato P
Tamoxifen and alpha interferon in advanced breast cancer.
Journal of chemotherapy (Florence, Italy) 1991;3(6):383-6.
-
1991: Queirolo P; Repetto L; Gardin G; Miglietta L; Guido T; Pronzato P; Rosso R
Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 1991;3(3):194-7.
-
1991: Rosso R; Amoroso D; Gardin G; Miglietta L; Guido T; Pace M; Repetto L; Pronzato P
Lonidamine in metastatic breast cancer.
Seminars in oncology 1991;18(2 Suppl 4):62-5.
-
1991: Pronzato P; Queirolo P; Vidili M G; Amoroso D; Bertelli G; Sertoli M R; Rosso R
Continuous venous infusion of vinblastine in metastatic breast cancer.
Chemotherapy 1991;37(2):146-9.
-
1991: Pronzato P; Bertelli G; Amoroso D; Pennucci C; Gardin G; Guido T; Rosso P
Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancer.
Chemotherapy 1991;37(6):449-53.
-
1990: Conte P F; Gardin G; Pronzato P; Miglietta L; Rosso R; Amadori D; Gentilini P; Monzeglio C; Gallotti P; Demicheli R
In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.
The Journal of steroid biochemistry and molecular biology 1990;37(6):1103-8.
-
1990: Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli M R; Rosso R
Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
Anticancer research 1990;10(6):1743-5.
-
1990: Pronzato P; Brema F; Amoroso D; Bertelli G; Conte P F; Martini M C; Pastorino G; Rosso R
Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
Breast cancer research and treatment 1990;17(1):51-4.
-
1990: Pronzato P; Bertelli G; Amoroso D; Gozza A; Zaniboni A; Marini G; Rosso R
Cisplatin and recombinant alpha interferon in advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):150-1.
-
1989: Pronzato P; Campora E; Amoroso D; Bertelli G; Botto F; Conte P F; Sertoli M R; Rosso R
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.
American journal of clinical oncology 1989;12(6):481-5.
-
1989: Rosso R; Boccardo F; Brema F; Sertoli M R; Amoroso D; Bertelli G; Pronzato P
Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
Anticancer research 1989;9(4):1153-6.
-
1989: Ardizzoni A; Pennucci C; Fusco V; Gulisano M; Bonavia M; Pronzato P; De Palma M; Serrano J; Rosso R
Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposide.
Anticancer research 1989;9(4):937-9.
-
1989: Pronzato P; Amoroso D; Bertelli G; Conte P F; Cusimano M P; Ciottoli G B; Gulisano M; Lionetto R; Rosso R
Phase II study of lonidamine in metastatic breast cancer.
British journal of cancer 1989;59(2):251-3.
-
1989: Amoroso D; Bertelli G; Pronzato P; Vidili M G; Gulisano M; Lionetto R; Rosso R
Continuous venous infusion of vindesine in metastatic breast cancer: experience with a subcutaneously implanted system and portable pump.
Anticancer research 1989;9(1):141-3.
-
1989: Canavese G; Catturich A; Battistini G; Caroti C; Pronzato P; Gardin G; Amoroso D; Bertelli G; Conte P F; Tomao S
The role of surgery in the combined treatment of locally advanced breast cancer.
Oncology 1989;46(6):353-6.
-
1988: Bertelli G; Pronzato P; Amoroso D; Cusimano M P; Conte P F; Montagna G; Bertolini S; Rosso R
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.
Breast cancer research and treatment 1988;12(3):307-10.
-
1988: Bertelli G; Amoroso D; Pronzato P; Rosso R
Idarubicin: an evaluation of cardiac toxicity in 77 patients with solid tumors.
Anticancer research 1988;8(4):645-6.
-
1988: Amoroso D; Pronzato P; Bertelli G; Gallotti P; Pastorino G; Cusimano M P; Merlano M; Conte P F; Rosso R
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study.
Breast cancer research and treatment 1988;11(3):269-71.
-
1988: Pronzato P; Ardizzoni A; Lionetto R; Conte P F; Rosso R
Tamoxifen rechallenge.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):751-2.
-
1988: Ardizzoni A; Pronzato P; Repetto L; De Palma M; Canobbio L; Gulisano M; Fusco V; Rosso R; Ganzina F
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC).
Cancer investigation 1988;6(4):409-11.
-
1987: Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
Cancer treatment reports 1987;71(12):1311-2.
-
1987: Pronzato P; Amoroso D; Ardizzoni A; Bertelli G; Conte P F; Michelotti A; Rosso R
A phase II study with danazol in metastatic breast cancer.
American journal of clinical oncology 1987;10(5):407-9.
-
1987: Pronzato P; Amoroso D; Ardizzoni A; Bertelli G; Canobbio L; Conte P F; Cusimano M P; Fusco V; Gulisano M; Lionetto R
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer.
American journal of clinical oncology 1987;10(5):404-6.
-
1987: Conte P F; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):712-3.
-
1987: Rosso R; Ardizzoni A; Conte P; Fusco V; Gulisano M; Lionetto R; Pronzato P; Repetto L
Phase II trials of idarubicin, a new anthracycline.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):694.
-
1987: Conte P F; Pronzato P; Rubagotti A; Alama A; Amadori D; Demicheli R; Gardin G; Gentilini P; Jacomuzzi A; Lionetto R
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):339-47.
-
1987: Repetto L; Pronzato P; Ardizzoni A; Bertelli G; Gulisano M; Amoroso D; Gardin G; Fusco V; Falcone A; Conte P F
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(1):66-72.
-
1987: Lionetto R; Pronzato P; Conte P F; Amoroso D; Badellino F; Bertelli G; Canavese G; Gardin G; Rosso R
Multimodality treatment of locally advanced breast cancer.
Oncology 1987;44(3):137-41.
-
1986: Lionetto R; Pronzato P; Conte P F; Sertoli M R; Amoroso D; Rosso R
Idarubicin in advanced breast cancer: a phase II study.
Cancer treatment reports 1986;70(12):1439-40.
-
1986: Ardizzoni A; Canobbio L; Pronzato P; Repetto L; Serrano J; Benvenuto F; Simonassi C; Baracco F; Faravelli B; Nosenzo M
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1986;5(6):416-9.
-
1986: Ardizzoni A; Canobbio L; Pronzato P; Rubagotti A; De Palma M; Baracco F; Serrano J; Serrano S; Faravelli B; Nosenzo M
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung.
Cancer treatment reports 1986;70(7):891-2.
-
1986: Pronzato P; Ardizzoni A; Conte P F; Gulisano M; Lionetto R; Repetto L; Scornavacche V; Sertoli M R; Rosso R
A phase II study of mitoxantrone in advanced breast cancer.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1986;5(3):150-3.
-
1986: Lionetto R; Pronzato P; Bertelli G F; Ardizzoni A; Conte P F; Rosso R
Survival of patients with relapsing breast cancer: analysis of 302 patients.
Oncology 1986;43(5):278-82.
-
1985: Pronzato P; Ardizzoni A; Lionetto R; Conte P; Rosso R
Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer.
Tumori 1985;71(3):297-300.
-
1985: Ardizzoni A; Lionetto R; Repetto L; Pronzato P; Rosso R
[Salvage chemotherapy with mitomycin C and vindesine in metastatic carcinoma of the breast]
Giornale italiano di chemioterapia 1985;32(1):61-2.
-
1985: Nobile M T; Pronzato P; Campora E; Ardizzoni A; Grimaldi A; Lionetto R; Repetto L; Rosso R
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]
Giornale italiano di chemioterapia 1985;32(1):29-30.
-
1985: Lionetto R; Ardizzoni A; Repetto L; Pronzato P; Sertoli M R; Rosso R
[Phase II study of 4-demethoxydaunorubicin in metastatic breast neoplasms]
Giornale italiano di chemioterapia 1985;32(1):59-60.
-
1985: Ardizzoni A; Pronzato P; Canobbio L; Lionetto R; Rosso R
Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.
Journal of cancer research and clinical oncology 1985;110(1):77-8.
Sign-in to see more
